INNOVATOR IBD ETF LEADERS ETF

INNOVATOR IBD ETF LEADERS ETF

ETF · US45782C2017 (ARCX)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of INNOVATOR IBD ETF LEADERS ETF
No Price
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 291.684,00
Asset Allocation
AssetPercentage %
Stock US79,95 %
Stock non-US19,30 %
Cash0,74 %
NotClassified0,00 %
Other0,00 %
Bond0,00 %
Largest Positions
SymbolISINNamePercentage %
KRBNKraneShares Global Carbon ETF 14,17 %
SPYSPDR S&P 500 ETF Trust 7,12 %
XRTSPDR S&P Retail ETF 7,11 %
SPHBInvesco S&P 500 High Beta ETF 7,02 %
XHBSPDR S&P Homebuilders ETF 6,74 %
FXOFirst Trust Financials AlphaDEX Fund 4,61 %
KBWBInvesco Exchange-Traded Fund Trust II - Invesco KBW Bank ETF 4,49 %
IATiShares U.S. Regional Banks ETF 4,47 %
PSCEInvesco S&P SmallCap Energy ETF 4,06 %
AMZAInfraCap MLP ETF 4,01 %
Region Distribution
RegionPercentage %
North America74,71 %
Asia Emerging13,63 %
Australasia3,43 %
Asia Developed3,18 %
Europe Developed1,73 %
Japan1,61 %
Latin America0,81 %
Europe Emerging0,49 %
United Kingdom0,23 %
Africa/Middle East0,11 %
Sector Distribution
SectorPercentage %
Finanzdienstleistungen39,09 %
Grundstoffe14,56 %
Technologie11,69 %
Industrieunternehmen11,04 %
Verbrauchsgüter10,78 %
Gesundheitswesen4,47 %
Telekommunikation3,73 %
Basiskonsumgüter2,10 %
Immobilien0,87 %
Versorgungsunternehmen0,84 %
Company Profile for INNOVATOR IBD ETF LEADERS ETF ETF
The investment seeks to track, before fees and expenses, the performance of the IBD® ETF Leaders Index. The fund normally invests at least 80% of its net assets (including investment borrowings) in the exchange-traded investment companies that comprise the index. It generally invests in all of the securities comprising the index in proportion to the weightings of the securities in the index. The index is a rules-based index owned and developed by Investor's Business Daily® designed to attempt to outperform the broader equity and fixed income markets. The fund is non-diversified.
Fund Master Data
Issuer Innovator
Asset Class ETF
Name Innovator IBD ETF Leaders ETF
Fund Currency USD
Category Large Growth
Morningstar Rating 1
Fund Key Figures
Fund Size 8.240,09 EUR
Investment Strategy
The investment seeks to track, before fees and expenses, the performance of the IBD® ETF Leaders Index. The fund normally invests at least 80% of its net assets (including investment borrowings) in the exchange-traded investment companies that comprise the index. It generally invests in all of the securities comprising the index in proportion to the weightings of the securities in the index. The index is a rules-based index owned and developed by Investor's Business Daily® designed to attempt to outperform the broader equity and fixed income markets. The fund is non-diversified.

Company Data

Name INNOVATOR IBD ETF LEADERS ETF
Company Innovator IBD ETF Leaders ETF
Primary Exchange ARCX NYSE
ISIN US45782C2017
Asset Class ETF
Sector Financial Services
Industry Asset Management
Country United States of America
Currency USD
Employees -
IPO Date 2017-12-20
Dividends from 'INNOVATOR IBD ETF LEADERS ETF'
Ex-Date Dividend per Share
30.12.2020 0,02 USD
29.06.2020 0,17 USD
30.12.2019 0,13 USD
28.03.2019 0,15 USD
27.12.2018 0,09 USD
28.12.2017 0,05 USD

Ticker Symbols

Name Symbol
AMEX LDRS
More Shares
Investors who hold INNOVATOR IBD ETF LEADERS ETF also have the following shares in their portfolio:
ABCELLERA BIOLOGICS INC
ABCELLERA BIOLOGICS INC Share
SIGMA FINANCE CORPORATION (DO NOT PROCESS LINE REMOVALS / REDEMPTIONS) FLTG RTE CAP NTS 30/09/09
SIGMA FINANCE CORPORATION (DO NOT PROCESS LINE REMOVALS / REDEMPTIONS) FLTG RTE CAP NTS 30/09/09 Bond